Tony Budden - Psyence Biomedical Chief Officer
| PBMWW Stock | 0.01 0.0005 6.76% |
Executive
Tony Budden is Chief Officer of Psyence Biomedical Ltd
| Address | 121 Richmond Street West, Toronto, ON, Canada, M5H2K1 |
| Phone | 416-346-7764 |
| Web | https://www.psyencebiomed.com |
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Robert Vilsack | Park Ohio Holdings | 63 | |
| Kimberly Maready | Old Dominion Freight | 53 | |
| Colton Snow | Sun Country Airlines | N/A | |
| Craig Keller | Everus Construction Group | N/A | |
| Sharon Purnell | Stepan Company | 46 | |
| Jason Behring | Everus Construction Group | N/A | |
| Steven Hartsell | Old Dominion Freight | 56 | |
| Eric JD | Sun Country Airlines | 42 | |
| Jason Morris | Norfolk Southern | N/A | |
| Mark Mydlach | Stepan Company | N/A | |
| Raymond Kelly | Everus Construction Group | N/A | |
| Chris Ford | Everus Construction Group | N/A | |
| Matthew Rice | Stepan Company | N/A | |
| Christopher Allen | Sun Country Airlines | N/A | |
| Robert Haire | Stepan Company | 51 | |
| Eric Levenhagen | Sun Country Airlines | 42 | |
| Luke Nichols | Norfolk Southern | N/A | |
| Brian Davis | Sun Country Airlines | 43 | |
| Adrienne Riehl | Everus Construction Group | N/A | |
| Britney Hendricks | Everus Construction Group | N/A | |
| Sam Faucette | Old Dominion Freight | N/A | |
Management Performance
| Return On Asset | -1.26 |
Psyence Biomedical Leadership Team
Elected by the shareholders, the Psyence Biomedical's board of directors comprises two types of representatives: Psyence Biomedical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Psyence. The board's role is to monitor Psyence Biomedical's management team and ensure that shareholders' interests are well served. Psyence Biomedical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Psyence Biomedical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Taryn Vos, General Counsel | ||
| Jody Aufrichtig, Executive CoFounder | ||
| Neil MD, CEO Director | ||
| Tony Budden, Chief Officer | ||
| MaryElizabeth Gifford, Executive Impact | ||
| Warwick CordenLloyd, Chief Officer |
Psyence Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Psyence Biomedical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -1.26 | ||||
| Number Of Shares Shorted | 45.99 K | ||||
| EBITDA | (2.75 M) | ||||
| Book Value Per Share | (0.82) X | ||||
| Beta | -0.42 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Psyence Stock Analysis
When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.